EN
Product
  • Product
  • News

MicroPort EP Obtains Brazil ANVISA Approval

2020-02-10 09:25:00      Views:

Shanghai, China – On February 10, ShanghaiMicroPort EP MedTech Co., Ltd. (“MicroPort EP”) obtained the registrationcertificates of Brazil ANVISA for its in-house developed Columbus™ 3D EPNavigation System and Columbus™ External Reference Patch.


Columbus™ 3D EP Navigation System andColumbus™ External Reference Patch are indicated for collecting and analyzing cardiacelectrophysiological activity, providing real-time display of the human heartwith 3D graphics. The Brazil ANVISA approval means this product will soon enterthe Brazil market and lay a great foundation for MicroPort EP to furtherexpand the South American market.



Share:
Tel:
(86)(21)60969600
Add:  Building 28, Lane 588, Tianxiong Road. Shanghai, P. R. China
©Copyright 2023, Shanghai MicroPort EP MedTech Co., Ltd. All rights reserved.
Website License Number:Shanghai ICP Record No.16034362

Internet Drug Information Service Qualification Certificate Number: (Shanghai) - non operational - 2016-0126

  • Home
  • Tel
  • Top